groove

Penn Center for AIDS Research

Donald L. Siegel

faculty photo
Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Attending Physician, Dept. Pathology & Lab Med, Penn-Presbyterian Medical Center
Director, ACGME-accredited Fellowship Program in Blood Banking/Transfusion Medicine, Hospital of the University of PA
Medical Director, AABB-accredited Blood Bank and Apheresis Unit, Hospital of the University of Pennsylvania
Member for Oversight of Blood Usage, Clinical Effectiveness and Quality Improvement Committee, Hospital of the University of PA
Medical Director, FACT-accredited cell collection and processing facilities for Hematopoietic Stem Cell Transplant Program, Hospital of the University of Pennsylvania
Member, Executive Committee, Dept of Pathology & Lab Med, University of Pennsylvania School of Medicine
Attending Physician, Division of Transfusion Med, Dept. Pathology & Lab Med, Hospital of the University of PA
Founding Director, Division of Transfusion Medicine & Therapeutic Pathology, Hospital of the University of PA
Member, Cell & Vaccine Production Facility Advisory Committee, University of Pennsylvania School of Medicine
Director, Clinical Cell and Vaccine Production Facility, Center for Advanced Cellular Therapeutics, University of Pennsylvania School of Medicine
Department: Pathology and Laboratory Medicine

Contact information
9-112 South Tower, Big 421
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: (215) 662-3942
Lab: (215) 898-9655
Education:
Sc.B. (Biophysics)
Brown University, 1977.
Ph.D. (Biophysics)
Harvard University, 1983.
M.D.
University of Pennsylvania, 1987.
Post-Graduate Training
Resident in Clinical Pathology, HUP, Philadelphia, PA, 1987-1989.
Chief Resident, Division of Laboratory Medicine, HUP, Philadelphia, PA, 1989-1990.
Fellowship, Transfusion Medicine, HUP, Philadelphia, PA, 1990-1991.
Academic Medical Leadership Program, The Wharton School of the University of Pennsylvania, Philadelphia, PA, 2007-2008.
Penn Medicine Leadership Forum, The Wharton School of the University of Pennsylvania, Philadelphia, PA, 2008-2009.
Certifications
The American Board of Pathology, 1992.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Research Interests

Discovery and characterization of diagnostic and therapeutic monoclonal antibodies

Research Summary

My laboratory studies human immune repertoires in health and disease using phage display technologies for the production of human and non-human monoclonal antibodies relevant to transfusion medicine, benign hematology, infectious diseases, and oncology. Current studies focus on developing targeted drug delivery methods using red cell antibodies coupled to novel anti-thrombotic/anti-inflammatory molecules; cloning monoclonal primate neutralizing Dengue, Ebola, MERS and Zika virus antibodies for human in vivo antibody gene expression therapy; and isolating recombinant human and humanized antibody fragments for the design of T-cell chimeric antigen receptors for cancer therapy.

Description of Clinical Expertise

transfusion medicine, blood banking, apheresis, hematopoietic stem cell collection/processing, cGMP manufacture of cellular therapies for phase I first-in-human clinical trials

Selected Publications

Glassman, P.M., Villa, C.H., Marcos-Contreras, O.A., Hood, E.D., Walsh, L.R., Greineder, C.F., Myerson, J.W., Shuvaeva, T., Puentes, L., Brenner, J.S., Siegel, D.L., Muzykantov, V.R.: Targeted in vivo loading of red blood cells markedly prolongs nanocarrier circulation. J. Bioconjugate Chem in press, 2022.

Narayan, V., Barber-Rotenberg, J.S., Jung, I.Y., Lacey, S.F., Rech, A.J., Davis, M.M., Hwang, W.-T., Lai, P., Carpenter, E.L., Maude, S.L., Plesa, G., Vapiwala, N., Chew, A., Moniak, M., Sebro, R.A., Farwell, M.D., Marshall, A., Gilmore, J., Lledo, L., Dengel, K., Church, S.e., Hether, T.D., Xu, J., Gohil, M., Buckingham, T.H., Yee, S.S., Gonzalez, V.E., Kulikovskaya, I., Chen, F., Tian, L., Tien, K., Gladney, W., Nobles, C.L., Raymond, H., Prostate Cancer Cellular Therapy Program Investigators, Hexner, E.O., Siegel, D.L., Bushman, F.D., June, C.H., Fraietta, J.A., Haas, N.B.: PSMA-redirected TGFbeta-insensitive armored CAR T cell to treat metastatic castration resistant prostate cancer. Nature Medicine 28: 724-734, 2022.

Melenhorst, J.J., Chen, G.M., Wang, M., Porter, D.L., Gao, P., Bandyopadhyay, S., Pruteanu-Malinici, I., Nobles, C.L., Maji, S., Frey, N.V., Gill, S.I., Tian, L., Kulikovskaya, I., Gupta, M., Davis, M.M., Fraietta, J.A., Brogdon, J.L., Young, R.M., Ambrose, D.E., Chew, A., Levine, B.L., Siegel, D.L., Alanio, C., Wherry, E.J., Bushman, F.D., Lacey, S.F., Tan,, K., June, C.H.: Decade-long remissions of leukemia sustained by the persistence of activated CD4+ CAR T-cell. Nature 602: 503-509, 2022.

Gill, S., Vides, V., Frey, N.V., Hexner, E., Metzger, S., O'Brien, M., Hwang, W-T, Brogdon, J.L., Davis, M.M., Fraietta, J.A., Gaymon, A.L., Gladney, W.L., Lacey, S.F., Lamontagne, A., Mato, A.R., Maus, M.V., Melenhorst, J.J., Pequignot, E., Ruella, M., Shestov, M., Byrd, J.C., Schuster, S.J., Siegel, D.L., Levine, B.L., June, C.H., Porter, D.L.: Anti-CD19 CAR T cells in combination with Ibrutinib for the treatment of chronic lymphocytic leukemia. Blood Advances in press, 2022.

Tebas, P., Jadlowsky, J.K., Shaw, P.A., Tian, L., Esparza, E., Brennan, A., Kim, S., Naing, S.Y., Richardson, M.W., Vogel, A.N., Maldini, C., Kong, H., Liu, X., Lacey, S.F., Bauer, A.M., Mampe, F., Lee, G., Dale Ando, D., Levine, B.D., Porter, D.L., Zhao, Y., Siegel, D.L., Bar, K.J., June, C.H., Riley, J.L.: CCR5-edited CD4 T cells augment HIV-specific immunity to enable post rebound control of HIV replication. J. Clin. Invest. 131, 2021.

Tutwiler, V., Litvinov, R.I., Protopopova, A., Nagaswami, C., Villa, C., Abdulmalik, O., Siegel, D.L., Eric Russell, E.R., Muzykantov, V.R., Lam, W.A., Myers, D.R., Weisel, J.W.: Pathologically stiff erythrocytes can promote thrombosis by impeding contraction of blood clots. J. Thromb. Haemost. 19: 2894-2895, 2021.

Myers, R.M., Li, Y., Leahy, A.B., Barrett, D.M., Teachey, D.T., Callahan, C., Fasano, C.C., Rheingold, S.R., Amanda DiNofia, A., Wray, L. Aplenc, R., Baniewicz, D., Liu, H., Shaw, P.A., Pequignot, E., Getz, K.D., Brogdon, J.L., Fesnak, A.D., Siegel, D.L., Davis, M.M., Bartoszek, C., Lacey, S.F., Hexner, E.O., Chew, A., Wertheim, G.B., Levine, B.L., June, C.H., Grupp, S.A., Maude, S.L.: Humanized CD19-targeted Chimeric Antigen Receptor (CAR) T cells in CAR-naïve and CAR-exposed children and young adults with relapsed/refractory acute lymphoblastic leukemia. J. Clin. Oncol. 39: 3044-3055, 2021.

Halkidis, K., Siegel, D.L., Zheng, X.L.: A human monoclonal antibody against the C-terminus of ADAMTS13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura. J. Thromb. Haemost. 19: 1888-1895, 2021.

Bar, K.J., Shaw, P.A., Choi, G.H., Aqui, N., Fesnak, A., Yang, J.B., Soto-Calderon, H., Grajales, L., Starr, J., Andronov, M., Mastellone, M., Amonu, C., Feret, G., DeMarshall, M., Buchanan, M., Caturla, M., Gordon, J., Wanicur, A., Monroy, M.A., Mampe, F., Lindemuth, E., Gouma, S., Mullin, A.M., Barilla, H., Pronina, A., Irwin, L., Thomas, R., Eichinger, R.A., Demuth, F., Luning Prak, E.T., Pascual, J.L., Short, W., Elovitz, M.A., Baron, J., Meyer, N.J., Degnan, K.O., Frank, I., Hensley, S., Siegel, D.L., Tebas, P.: A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia. J. Clin. Invest. 131, 2021.

Bhoj, V., Li,, L., Parvathaneni, K., Zhang, Z., Kacir, S., Arhontoulis, D., Zhou, K., McGettigan-Croce, B., Nunez-Cruz, S., Gulendran,, G., Boesteanu, A.C., Johnson, L., Feldman, M.D., Radaelli, E., Mansfield, K., Nasrallah, M., Goydel,, R., Peng, H., Rader, C., Milone, M.C., Siegel, D.L.: Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4 (GFRa4). Molecular Therapeutic – Oncolytics 20: 387-398, 2021.

back to top
Last updated: 06/09/2022
The Trustees of the University of Pennsylvania